Top Markets
#1 MowCat MowCat +780.37%
#2 Islamic Coin Islamic Coin +152.09%
#3 龙虾 (Lobster) 龙虾 (Lobster) +85.02%
#4 Akedo Akedo +54.20%
#5 Magma Finance Magma Finance +42.91%
#6 MarsCoin MarsCoin +31.45%
#7 SIXSEVEN SIXSEVEN +30.60%
#8 DeXe DeXe +30.37%
#9 Cortex Cortex +26.31%
#10 Pons Pons +16.13%
Coin of the day
MowCat MowCat
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Kedudukan dalam Saham #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Harga Saham
$25.61
Disegerakkan terakhir: 2025-10-10
Modal Pasaran
$1.37B
Perubahan (1 hari)
0.20%
Perubahan (1 tahun)
1.59%
Negara
US
Perdagangan Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Kategori

Healthcare
Pendapatan untuk Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Harrow Health, Inc. 8.625% Senior Notes due 2026, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Harrow Health, Inc. 8.625% Senior Notes due 2026 dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT